What azelaic acid should I start with?

If your goal is rosacea, start with the 15% gel or foam

Start with the 15% gel or foam twice daily, and give it at least 12 weeks before you judge it. The FDA label for the 15% gel covers inflammatory papules and pustules of mild to moderate rosacea and directs a thin layer massaged in morning and evening.

The label advises reassessment if no improvement appears after 12 weeks. The 15% foam label carries the same 12-week check for continuous use.

The efficacy data are reasonably solid for a topical. In two vehicle-controlled phase III trials of 329 and 335 patients, inflammatory lesion reduction was 58% and 51%, against 40% and 39% for vehicle, according to Thiboutot and colleagues in JAAD00405-5/abstract). Clear, minimal, or mild IGA results were 61% and 62%, versus 40% and 48% for vehicle.

In a randomized trial against 0.75% metronidazole gel, 15% azelaic acid twice daily for 15 weeks did better on investigator global assessment and on erythema. That is a useful signal, not a verdict on every rosacea patient.

Once daily is not the labeled rosacea dose

Stick with twice daily for rosacea. An exploratory 12-week trial of 72 evaluable patients found no significant difference between once- and twice-daily 15% gel on lesion counts or IGA. The study is small and exploratory, so it does not change the labeled directions.

For acne, the 20% cream is the reference, starting once daily

Over the counter, azelaic acid comes as a 20% cream and lotion for mild comedonal and inflammatory acne. DermNet advises cleansing first, starting once daily, and building to twice daily if your skin tolerates it.

That is clinical guidance, not dosing derived from a trial. Trial-level detail on the 20% cream is thin in the sources we found. The closest comparison is a Cochrane-style acne review, which used 15% gel twice daily for four months against 5% benzoyl peroxide in 176 and 175 patients.

If you want the broader picture, our azelaic acid guide covers the basics.

Why 10% and 30% are not on this list

We found no randomized trial comparing 10%, 15%, and 20% starting strengths, and no titration protocol. No source we retrieved gives trial data for a 10% product, so we can't say it performs like the 15% or 20% versions.

The only 30% mention came from a narrative review, not a guideline or trial. Concentration choice is largely extrapolated from labeled products, which is why we're flagging it as a gap rather than a recommendation.

Safety and skin tone: what to watch for

The most common effects are transient stinging, burning, itching, or scaling, usually in the first few weeks. The FDA safety section lists these as the main reactions.

Isolated hypopigmentation reports exist, and the label notes that azelaic acid has not been well studied in darker complexions. Monitor those patients closely. Rare reported effects include vitiligo, hypertrichosis, and worsening asthma.

Systemic exposure looks low. Mean plasma levels with twice-daily 15% gel, 42 to 63.1 ng/mL, fell within the range seen with vehicle alone, per the 2005 FDA label.